SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (8249)1/8/1999 4:30:00 PM
From: LLCF  Read Replies (1) of 17367
 
<What is clear, is that if hu1124 eventually becomes a commercial product XOMA at its' option gets a cash payment(s) or profit sharing. The term royalties was not used, so I must assume they really meant profit sharing. But since the terms of the two options were not disclosed I have no idea of what either option will mean for XOMA.>

Thank-you very much... I was not aware of this. I am relatively new to XOMA, it is recommended by CTSL and MTSL as you know. This fall i decided that there was so much potential in biotech (all the articles that have been saying the next 5 years should see tons of approvals, blah blah blah... you know the story) that I would briefly look into 10 or 15 of those guys picks and buy 'em... so far I'm doing better than I ever thought, but want to really follow the stories as they unfold and hold some Long term.... and take profits in some, etc. Any help is appreciated.

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News